Search

Date 2019 Author/Creator Mehta, Amitkumar

2. Polatuzumab vedotin in combination with immunochemotherapy in patients with previously untreated diffuse large B-cell lymphoma: an open-label, non-randomised, phase 1b–2 study. Issue 7 (July 2019)

Authors:
Tilly, Hervé; Morschhauser, Franck; Bartlett, Nancy L; Mehta, Amitkumar; Salles, Gilles; Haioun, Corinne; Munoz, Javier; Chen, Andy I; Kolibaba, Kathryn; Lu, Dan; Yan, Mark; Penuel, Elicia; Hirata, Jamie; Lee, Calvin; Sharman, Jeff P
Journal:
Lancet oncology
Issue:
Volume 20:Issue 7(2019)
Page Start:
998
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Safety and activity of ibrutinib in combination with durvalumab in patients with relapsed or refractory follicular lymphoma or diffuse large B‐cell lymphoma. Issue 1 (6th November 2019)

Authors:
Herrera, Alex F.; Goy, Andre; Mehta, Amitkumar; Ramchandren, Radhakrishnan; Pagel, John M.; Svoboda, Jakub; Guan, Shanhong; Hill, John S.; Kwei, Kevin; Liu, Emily A.; Phillips, Tycel
Journal:
American journal of hematology
Issue:
Volume 95:Issue 1(2020:Jan.)
Page Start:
18
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗